Hemoglobin A1C (A1C) Reduction And Diabetes-Related Health Care Costs Among Type 2 Diabetes (T2DM) Patients Treated With Liraglutide or Exenatide- A Retrospective Claims Database Analysis
Nov 1, 2016, 00:00
10.1016/j.jval.2016.09.1839
https://www.valueinhealthjournal.com/article/S1098-3015(16)33205-3/fulltext
Title :
Hemoglobin A1C (A1C) Reduction And Diabetes-Related Health Care Costs Among Type 2 Diabetes (T2DM) Patients Treated With Liraglutide or Exenatide- A Retrospective Claims Database Analysis
Citation :
https://www.valueinhealthjournal.com/action/showCitFormats?pii=S1098-3015(16)33205-3&doi=10.1016/j.jval.2016.09.1839
First page :
A666
Section Title :
Disease-Specific Studies
Open access? :
No
Section Order :
1735